Cargando…

Clinical Features and Management of Women with Borderline Ovarian Tumors in a Single Center in Brazil

Objective The aim of the present study was to describe and analyze data of 57 women with borderline ovarian tumors (BOTs) regarding histological characteristics, clinical features and treatment management at the Department of Obstetrics and Gynecology of the Universidade Estadual de Campinas (Unicam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Adriana, Tavares, Bárbara Virginia Gonçalves, Sarian, Luís Otavio, Andrade, Liliana Aparecida Lucci Ângelo, Derchain, Sophie Françoise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316797/ https://www.ncbi.nlm.nih.gov/pubmed/30991432 http://dx.doi.org/10.1055/s-0039-1683415

Ejemplares similares

Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers
por: Gomes, Tiago Augusto, et al.
Publicado: (2020)

Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status
por: Sallum, Luis Felipe, et al.
Publicado: (2013)

Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses
por: Pitta, Denise da Rocha, et al.
Publicado: (2013)

Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
por: Yoshida, Adriana, et al.
Publicado: (2020)

Diffusion-weighted magnetic resonance sequence and CA125/CEA ratio can be used as add-on tools to ultrasound for the differentiation of ovarian from non-ovarian pelvic masses
por: Nunes Pereira, Patrick, et al.
Publicado: (2023)

WT1, p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis
por: Sallum, Luis Felipe, et al.
Publicado: (2018)

Influence of Gender and Undergraduate Course on the Knowledge about HPV and HPV Vaccine, and Vaccination Rate among Students of a Public University
por: Biselli-Monteiro, Marília, et al.
Publicado: (2020)

GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel‐Based Chemotherapy in Ovarian Cancer
por: Ferracini, Amanda Canato, et al.
Publicado: (2020)

Assessment of the performance of the O-RADS MRI score for the evaluation of adnexal masses, with technical notes
por: Pereira, Patrick Nunes, et al.
Publicado: (2022)

Retrieval of HPV oncogenes E6 and E7 mRNA from cervical specimens using a manual open technology protocol
por: Campbell, Leonardo Martins, et al.
Publicado: (2013)

CAISMOV24, a new human low-grade serous ovarian carcinoma cell line
por: da Silva, Rodrigo Fernandes, et al.
Publicado: (2017)

Exosome-mediated breast cancer chemoresistance via miR-155 transfer
por: Santos, Juliana Carvalho, et al.
Publicado: (2018)

Strict Criteria for Selection of Laparoscopy for Women with Adnexal Mass
por: Barreta, Amilcar, et al.
Publicado: (2014)

Bayesian Estimation of Performance Measures of Cervical Cancer Screening Tests in the Presence of Covariates and Absence of a Gold Standard
por: Martinez, Edson Zangiacomi, et al.
Publicado: (2008)

Clinicopathologic features of ovarian neoplasms with emphasis on borderline ovarian tumors: an institutional perspective
por: Hashmi, Atif Ali, et al.
Publicado: (2016)

Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine
por: Conceição, Miguel S., et al.
Publicado: (2021)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

The Multimodal Ultrasound Features of Ovarian Serous Surface Papillary Borderline Tumor
por: Xie, Lijun, et al.
Publicado: (2022)

RETROSPECTIVE ANALYSIS OF BORDERLINE OVARIAN TUMORS: OUTCOMES AT A SINGLE CENTER
por: Yilmaz, Ercan, et al.
Publicado: (2019)

Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer
por: Rabelo-Santos, Silvia Helena, et al.
Publicado: (2018)

Aluminum concentrations in central and peripheral areas of malignant breast lesions do not differ from those in normal breast tissues
por: Rodrigues-Peres, Raquel Mary, et al.
Publicado: (2013)

Polymorphisms of Glutathione S-Transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) Genes and Epithelial Ovarian Cancer Risk
por: Oliveira, Cristiane, et al.
Publicado: (2012)

Controversies in borderline ovarian tumors
por: Seong, Seok Ju, et al.
Publicado: (2015)

A portrait of single and multiple HPV type infections in Brazilian women of different age strata with squamous or glandular cervical lesions
por: Resende, Leandro Santos de Araújo, et al.
Publicado: (2014)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Management of borderline ovarian tumors: A tertiary referral center experience in Egypt
por: Gaballa, Khaled, et al.
Publicado: (2022)

Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients
por: da Silva, Rodrigo Fernandes, et al.
Publicado: (2017)

Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
por: Uehara, Takashi, et al.
Publicado: (2020)

Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors
por: Xiao, Fuxia, et al.
Publicado: (2022)

Genomic aberrations in borderline ovarian tumors
por: Micci, Francesca, et al.
Publicado: (2010)

Copy number alterations associated with clinical features in an underrepresented population with breast cancer
por: Rodrigues‐Peres, Raquel M., et al.
Publicado: (2019)

Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial
por: de Oliveira, Mariana Maia Freire, et al.
Publicado: (2018)

Three-Dimensional Cell Culture Based on Magnetic Fields to Assemble Low-Grade Ovarian Carcinoma Cell Aggregates Containing Lymphocytes
por: Natânia de Souza-Araújo, Caroline, et al.
Publicado: (2020)

Borderline shades: Morphometric features predict borderline personality traits but not histrionic traits
por: Langerbeck, Miriam, et al.
Publicado: (2023)

Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland
por: Kipp, B., et al.
Publicado: (2023)

Staging recurrent ovarian cancer with (18)FDG PET/CT
por: DRAGOSAVAC, SANJA, et al.
Publicado: (2013)

Borderline ovarian tumors: a review of treatment.
por: Chambers, J. T.
Publicado: (1989)

Fertility sparing treatment in borderline ovarian tumours
por: Alvarez, Rosa Maria, et al.
Publicado: (2015)

Fertility Sparing Surgery and Borderline Ovarian Tumours
por: Kasaven, Lorraine S., et al.
Publicado: (2022)

Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors
por: Plett, Helmut, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_551tfbndo9keap56njkk5qcvqi